Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Change in Account Payables (2016 - 2025)

Bio Key International's Change in Account Payables history spans 16 years, with the latest figure at -$233331.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables fell 2294.61% year-over-year to -$233331.0; the TTM value through Sep 2025 reached -$913636.0, down 401.85%, while the annual FY2024 figure was -$502987.0, 971.35% down from the prior year.
  • Change in Account Payables for Q3 2025 was -$233331.0 at Bio Key International, down from $330893.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $638617.0 in Q2 2023 and bottomed at -$1.0 million in Q4 2021.
  • The 5-year median for Change in Account Payables is -$83.0 (2022), against an average of -$9711.2.
  • The largest annual shift saw Change in Account Payables soared 879.96% in 2021 before it plummeted 518806.02% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$1.0 million in 2021, then surged by 99.99% to -$83.0 in 2022, then tumbled by 518806.02% to -$430692.0 in 2023, then crashed by 74.52% to -$751627.0 in 2024, then skyrocketed by 68.96% to -$233331.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Change in Account Payables are -$233331.0 (Q3 2025), $330893.0 (Q2 2025), and -$259571.0 (Q1 2025).